# A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer

> **NCT00793962** · PHASE3 · COMPLETED · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 810 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** hypofractionation radiotherapy
- **RADIATION:** conventional fractionation radiotherapy

## Key facts

- **NCT ID:** NCT00793962
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2016-05
- **Final completion:** 2018-09
- **Target enrollment:** 810 (ACTUAL)
- **Last updated:** 2018-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00793962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00793962, "A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00793962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*